Advertisement
NNCSF vs PYNKF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NNCSF is a Hold and PYNKF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NNCSF’s FA Score shows that 0 FA rating(s) are green whilePYNKF’s FA Score has 1 green FA rating(s).
- NNCSF’s FA Score: 0 green, 5 red.
- PYNKF’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NNCSF’s TA Score shows that 3 TA indicator(s) are bullish while PYNKF’s TA Score has 5 bullish TA indicator(s).
- NNCSF’s TA Score: 3 bullish, 4 bearish.
- PYNKF’s TA Score: 5 bullish, 4 bearish.
Price Growth
NNCSF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while PYNKF (@Medical/Nursing Services) price change was -21.24% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.44%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was +7.03%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.02%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +6.23%.
Reported Earning Dates
PYNKF is expected to report earnings on Mar 26, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+1.44% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+0.02% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| NNCSF | PYNKF | NNCSF / PYNKF | |
| Capitalization | 807M | 15.3M | 5,275% |
| EBITDA | 31.8M | -15.46M | -206% |
| Gain YTD | 36.190 | -37.500 | -97% |
| P/E Ratio | 65.41 | N/A | - |
| Revenue | 199M | 1.56M | 12,773% |
| Total Cash | 161M | 1.37M | 11,786% |
| Total Debt | 7.69M | 117K | 6,569% |
NNCSF | PYNKF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 78 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 51 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 67 | 100 | |
PRICE GROWTH RATING 1..100 | 50 | 82 | |
P/E GROWTH RATING 1..100 | 55 | 3 | |
SEASONALITY SCORE 1..100 | 75 | 46 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PYNKF's Valuation (51) in the null industry is somewhat better than the same rating for NNCSF (99). This means that PYNKF’s stock grew somewhat faster than NNCSF’s over the last 12 months.
PYNKF's Profit vs Risk Rating (100) in the null industry is in the same range as NNCSF (100). This means that PYNKF’s stock grew similarly to NNCSF’s over the last 12 months.
NNCSF's SMR Rating (67) in the null industry is somewhat better than the same rating for PYNKF (100). This means that NNCSF’s stock grew somewhat faster than PYNKF’s over the last 12 months.
NNCSF's Price Growth Rating (50) in the null industry is in the same range as PYNKF (82). This means that NNCSF’s stock grew similarly to PYNKF’s over the last 12 months.
PYNKF's P/E Growth Rating (3) in the null industry is somewhat better than the same rating for NNCSF (55). This means that PYNKF’s stock grew somewhat faster than NNCSF’s over the last 12 months.
| NNCSF | PYNKF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 50% | N/A |
| Stochastic ODDS (%) | 2 days ago 40% | 3 days ago 75% |
| Momentum ODDS (%) | 2 days ago 44% | 3 days ago 87% |
| MACD ODDS (%) | 2 days ago 44% | 3 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 46% | 3 days ago 68% |
| TrendMonth ODDS (%) | 2 days ago 51% | 3 days ago 68% |
| Advances ODDS (%) | N/A | 19 days ago 76% |
| Declines ODDS (%) | 18 days ago 64% | N/A |
| BollingerBands ODDS (%) | 2 days ago 56% | 3 days ago 72% |
| Aroon ODDS (%) | 2 days ago 53% | 3 days ago 69% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JNUSX | 19.95 | -0.07 | -0.35% |
| JPMorgan Developed International Value L | |||
| TIGCX | 21.72 | -0.21 | -0.96% |
| Thornburg International Growth C | |||
| PJEQX | 15.63 | -0.16 | -1.01% |
| PGIM US Real Estate R6 | |||
| MFQAX | 18.40 | -0.22 | -1.18% |
| AMG Veritas Global Focus N | |||
| JAGIX | 80.52 | -1.38 | -1.68% |
| Janus Henderson Growth And Income T | |||
NNCSF and
Correlation & Price change
A.I.dvisor tells us that NNCSF and ASAPF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and ASAPF's prices will move in lockstep.
| Ticker / NAME | Correlation To NNCSF | 1D Price Change % | ||
|---|---|---|---|---|
| NNCSF | 100% | N/A | ||
| ASAPF - NNCSF | 21% Poorly correlated | -1.21% | ||
| NHNKY - NNCSF | 8% Poorly correlated | -6.44% | ||
| NHNKF - NNCSF | 0% Poorly correlated | N/A | ||
| NVYTF - NNCSF | 0% Poorly correlated | N/A | ||
| MRCHF - NNCSF | 0% Poorly correlated | N/A | ||
More | ||||
PYNKF and
Correlation & Price change
A.I.dvisor tells us that PYNKF and GKOS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYNKF and GKOS's prices will move in lockstep.
| Ticker / NAME | Correlation To PYNKF | 1D Price Change % | ||
|---|---|---|---|---|
| PYNKF | 100% | +1.18% | ||
| GKOS - PYNKF | 21% Poorly correlated | +3.03% | ||
| OSSUY - PYNKF | 6% Poorly correlated | N/A | ||
| PFGTF - PYNKF | 3% Poorly correlated | N/A | ||
| NNCSF - PYNKF | -0% Poorly correlated | N/A | ||
| NVYTF - PYNKF | -1% Poorly correlated | N/A | ||
More | ||||